Human Immunodeficiency Virus-specific CD8(+) T-cell Responses Do Not Predict Viral Growth and Clearance Rates During Structured Intermittent Antiretroviral Therapy

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 2002 Sep 20

PMID 12239291

Citations 19

Authors

Annette Oxenius

Angela R McLean

Marek Fischer

David A Price

Sarah J Dawson

Roland Hafner

Christine Schneider

Helen Joller

Bernard Hirschel

Rodney E Phillips

Rainer Weber

Huldrych F Gunthard

Affiliations

Soon will be listed here.

Abstract

There is a continuing search for better ways to use existing drugs against human immunodeficiency virus (HIV). One idea is to use short therapy interruptions to "autovaccinate" HIV-infected patients. A group of 13 chronically HIV-infected patients enrolled in a trial of such so-called structured treatment interruptions (STIs) were intensively studied with respect to their viral load (VL) and HIV-specific CD8+ T-cell (cytotoxic T-lymphocyte [CTL]) responses. We found that 10 of the 13 patients had plateau VLs after STIs that were lower than their pretreatment VLs. While viral rebound rates became lower over STIs, there were no changes in clearance rates. Although numbers of CTLs did increase over the same time that viral rebounds decreased, there was no correlation between CTL count and either viral rebound rates or clearance rates. Finally, we asked whether absolute numbers of or changes in numbers of CTLs predict plateau VLs after STIs. No measure of CTLs was able to predict plateau VLs. Thus, there was no signature in these data of an important contribution to virological control from HIV-specific CD8+ T lymphocytes.

Citing Articles

Nonlinear mixed-effects models for HIV viral load trajectories before and after antiretroviral therapy interruption, incorporating left censoring.

Gao S, Wu L, Yu T, Kouyos R, Gunthard H, Wang R Stat Commun Infect Dis. 2022; 14(1):20210001.

PMID: 35880974 PMC: 9204768. DOI: 10.1515/scid-2021-0001.

Predicting HIV-1 transmission and antibody neutralization efficacy in vivo from stoichiometric parameters.

Brandenberg O, Magnus C, Rusert P, Gunthard H, Regoes R, Trkola A PLoS Pathog. 2017; 13(5):e1006313.

PMID: 28472201 PMC: 5417720. DOI: 10.1371/journal.ppat.1006313.

Delineating CD4 dependency of HIV-1: Adaptation to infect low level CD4 expressing target cells widens cellular tropism but severely impacts on envelope functionality.

Beauparlant D, Rusert P, Magnus C, Kadelka C, Weber J, Uhr T PLoS Pathog. 2017; 13(3):e1006255.

PMID: 28264054 PMC: 5354460. DOI: 10.1371/journal.ppat.1006255.

In vivo CD8+ T-cell suppression of siv viremia is not mediated by CTL clearance of productively infected cells.

Wong J, Strain M, Porrata R, Reay E, Sankaran-Walters S, Ignacio C PLoS Pathog. 2010; 6(1):e1000748.

PMID: 20126442 PMC: 2813272. DOI: 10.1371/journal.ppat.1000748.

Interpreting the effect of vaccination on steady state infection in animals challenged with Simian immunodeficiency virus.

Sergeev R, Batorsky R, Coffin J, Rouzine I J Theor Biol. 2009; 263(3):385-92.

PMID: 20034499 PMC: 2827631. DOI: 10.1016/j.jtbi.2009.12.018.

References

Rosenberg E, Altfeld M, Poon S, Phillips M, Wilkes B, Eldridge R . Immune control of HIV-1 after early treatment of acute infection. Nature. 2000; 407(6803):523-6. DOI: 10.1038/35035103. View

Bunce M, ONeill C, Barnardo M, Krausa P, Browning M, Morris P . Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens. 1995; 46(5):355-67. DOI: 10.1111/j.1399-0039.1995.tb03127.x. View

Lori F, Lewis M, Xu J, Varga G, Zinn Jr D, Crabbs C . Control of SIV rebound through structured treatment interruptions during early infection. Science. 2000; 290(5496):1591-3. DOI: 10.1126/science.290.5496.1591. View

Sewell A, Price D, Oxenius A, Kelleher A, Phillips R . Cytotoxic T lymphocyte responses to human immunodeficiency virus: control and escape. Stem Cells. 2000; 18(4):230-44. DOI: 10.1634/stemcells.18-4-230. View

Ortiz G, Wellons M, Brancato J, Vo H, Zinn R, Clarkson D . Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects. Proc Natl Acad Sci U S A. 2001; 98(23):13288-93. PMC: 60863. DOI: 10.1073/pnas.221452198. View

Frost S, Martinez-Picado J, Ruiz L, Clotet B, Leigh Brown A . Viral dynamics during structured treatment interruptions of chronic human immunodeficiency virus type 1 infection. J Virol. 2002; 76(3):968-79. PMC: 135793. DOI: 10.1128/jvi.76.3.968-979.2002. View

Ruiz L, Carcelain G, Martinez-Picado J, Frost S, Marfil S, Paredes R . HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infection. AIDS. 2001; 15(9):F19-27. DOI: 10.1097/00002030-200106150-00001. View

Ogg G, Jin X, Bonhoeffer S, Dunbar P, Nowak M, Monard S . Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science. 1998; 279(5359):2103-6. DOI: 10.1126/science.279.5359.2103. View

Rosenberg E, Billingsley J, Caliendo A, Boswell S, Sax P, Kalams S . Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science. 1997; 278(5342):1447-50. DOI: 10.1126/science.278.5342.1447. View

10.

Appay V, Nixon D, Donahoe S, Gillespie G, Dong T, King A . HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med. 2000; 192(1):63-75. PMC: 1887711. DOI: 10.1084/jem.192.1.63. View

11.

Oxenius A, Gunthard H, Hirschel B, Fidler S, Weber J, Easterbrook P . Direct ex vivo analysis reveals distinct phenotypic patterns of HIV-specific CD8(+) T lymphocyte activation in response to therapeutic manipulation of virus load. Eur J Immunol. 2001; 31(4):1115-21. DOI: 10.1002/1521-4141(200104)31:4<1115::aid-immu1115>3.0.co;2-9. View

12.

Ortiz G, Nixon D, Trkola A, Binley J, Jin X, Bonhoeffer S . HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy. J Clin Invest. 1999; 104(6):R13-8. PMC: 408442. DOI: 10.1172/JCI7371. View

13.

Gea-Banacloche J, Migueles S, Martino L, Shupert W, McNeil A, Sabbaghian M . Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors. J Immunol. 2000; 165(2):1082-92. DOI: 10.4049/jimmunol.165.2.1082. View

14.

Lori F, Maserati R, Foli A, Seminari E, Timpone J, Lisziewicz J . Structured treatment interruptions to control HIV-1 infection. Lancet. 2000; 355(9200):287-8. DOI: 10.1016/S0140-6736(99)03515-1. View

15.

Binley J, Schiller D, Ortiz G, Hurley A, Nixon D, MARKOWITZ M . The relationship between T cell proliferative responses and plasma viremia during treatment of human immunodeficiency virus type 1 infection with combination antiretroviral therapy. J Infect Dis. 2000; 181(4):1249-63. DOI: 10.1086/315379. View

16.

Ogg G, Jin X, Bonhoeffer S, Moss P, Nowak M, Monard S . Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. J Virol. 1998; 73(1):797-800. PMC: 103892. DOI: 10.1128/JVI.73.1.797-800.1999. View

17.

Ho D, Neumann A, Perelson A, Chen W, Leonard J, Markowitz M . Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 1995; 373(6510):123-6. DOI: 10.1038/373123a0. View

18.

Garcia F, Plana M, Ortiz G, Bonhoeffer S, Soriano A, Vidal C . The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection. AIDS. 2001; 15(9):F29-40. DOI: 10.1097/00002030-200106150-00002. View

19.

Betts M, Ambrozak D, Douek D, Bonhoeffer S, Brenchley J, Casazza J . Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection. J Virol. 2001; 75(24):11983-91. PMC: 116093. DOI: 10.1128/JVI.75.24.11983-11991.2001. View

20.

Douek D, Brenchley J, Betts M, Ambrozak D, Hill B, Okamoto Y . HIV preferentially infects HIV-specific CD4+ T cells. Nature. 2002; 417(6884):95-8. DOI: 10.1038/417095a. View